This site uesd JavaScript.
TOP
>
News Release
> list in 2005
Back Number
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
Guide to Category Symbols
Corporate
R&D
Products
Others
2005.12.22:
Daiichi Defeats Mylan in Dispute Over $1 Billion Per Year Drug Patent
HTML
PDF
2005.12.14:
Transfer of a Portion of Sankyo Pharma GmbH Products
HTML
PDF
2005.12.06:
Third Sankyo Takamine Memorial Award Granted
HTML
PDF
2005.12.05:
Joint Research in Genome-based Target Discovery between Daiichi Pharmaceutical Co., Ltd. and Celestar Lexico-Sciences, Inc. has concluded
HTML
PDF
2005.11.25:
Establishment of the Healthcare Company
DAIICHI SANKYO HEALTHCARE CO., LTD.
HTML
PDF
2005.11.17:
Large Scale Clinical Trial MEGA Study* Employing the Hyperlipidemia Drug Mevalotin®
HTML
PDF
2005.11.04:
DISCONTINUATION OF MARKETING ALLIANCE FOR KETOLIDE ANTIBIOTICS, "KETEKR® TABLETS 300MG"
HTML
PDF
2005.10.28:
Announcement of Revised Results Forecasts of the Sub-subsidiary Wakodo Co., Ltd.
HTML
PDF
2005.10.26:
Discontinuation of Clinical Studies of CS-505
(Pactimibe; Sankyo's ACAT Inhibitor)
HTML
PDF
2005.10.17:
Report concerning revisions to the forecasted results of our sub-subsidiary company (Fuji Flour Milling Co., Ltd.)
HTML
PDF
2005.10.12:
Completion of the Registration of Trial Subjects for ORIENT on the Suppressive Effects of the Angiotensin II Receptor Blocker Olmetec® against the Progression of Diabetic Nephropathy
HTML
PDF
2005.10.07:
European Mutual Certification Completed for Antihypertensive
Olmetec Combination Drug
HTML
PDF
2005.09.28:
Establishment of DAIICHI SANKYO COMPANY, LIMITED
HTML
PDF
Back Number
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others